Skip to content

accuracy of a new tool for optimal placement of the acetabular component in Total Hip Arthroplasty

accuracy of a new tool for optimal placement of the acetabular component in Total Hip Arthroplasty - Guidewire trial

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34036
Enrollment
25
Registered
2010-10-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degeneration of the hipjoint osteoarthritis of the hip

Interventions

None listed

Sponsors

Isala Klinieken
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: patients who signed the informed consent patients who have symptomatic osteoarthritis of the hip and eligible for a total hiparthroplasty

Exclusion criteria

Exclusion criteria: standard contraindications, as prevailing for elective cemented total hip arthroplasty (infection, severe comorbidity of pulmonary, cardiac or metabolic nature).

Design outcomes

Primary

MeasureTime frame
the difference of perioperative measured inclination and anteversion (by using the device) compared to the values calculated on CT.

Secondary

MeasureTime frame
operating time, complications, such as: infection and pain at the entrancepoint of the markingpoint.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)